Download Free Sample Report

Cancer Therapeutics And Biotherapeutics Market, Global Outlook and Forecast 2022-2028

Cancer Therapeutics And Biotherapeutics Market, Global Outlook and Forecast 2022-2028

  • Published on : 06 July 2022
  • Pages :61
  • Report Code:SMR-7184888

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
This report contains market size and forecasts of Cancer Therapeutics And Biotherapeutics in Global, including the following market information:
  • Global Cancer Therapeutics And Biotherapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)
The global Cancer Therapeutics And Biotherapeutics market was valued at 8959.4 million in 2021 and is projected to reach US$ 11930 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Therapeutics And Biotherapeutics include Bristol-Myers Squibb, AstraZeneca, Pfizer, Biogen IDEC, Sanofi, Genentech, Novartis, Johnson & Johnson and Roche and Schering-Plough. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Therapeutics And Biotherapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Therapeutics And Biotherapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, by Type, 2021 (%)
  • Chemotherapy
  • Radiation Therapy
  • Hormone Therapy
  • Biotherapy
Global Cancer Therapeutics And Biotherapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, by Application, 2021 (%)
  • Consumption
  • Household
  • Hospital
Global Cancer Therapeutics And Biotherapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies Cancer Therapeutics And Biotherapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Cancer Therapeutics And Biotherapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
  • Bristol-Myers Squibb
  • AstraZeneca
  • Pfizer
  • Biogen IDEC
  • Sanofi
  • Genentech
  • Novartis
  • Johnson & Johnson
  • Roche and Schering-Plough